COVID-19 Recent Changes to Telehealth Regulations and Reimbursement
Recent changes from the Administration have helped physicians see more patients through telehealth services. This has been welcome…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2020
FDA Issues Guidance on Drug Shortage Notifications
In view of potential drug supply interruptions due to the COVID-19 pandemic, the US Food and Drug Administration (“FDA”) recently…
DOJ Brings FCA Suit Against Anthem for Inaccurate Diagnosis Data
The Department of Justice (“DOJ”) recently filed a False Claims Act suit alleging that Anthem falsely certified the accuracy of…
COVID-19 Burden Index Released
As our focus turns to not only beating COVID-19, but also opening our economy back up, Leavitt Partners Insight (LPI) launched a…
COVID-19 Pandemic Compliance Action Plan
On April 6, 2020, Global Health Care LLC held a webinar on a COVID-19 Pandemic Action Plan for Pharmaceutical and Medical Device…
Understanding FDA Regulatory Terminology During COVID-19
To update clinicians on the various terminology used by the FDA on treatments related to COVID-19 we have developed this reference…
The Impact COVID-19 is Having on ACOs
Recently, the National Association of Accountable Care Organizations (NAACOS) surveyed the Accountable Care Organization (ACO)…
CMS Issues Guidances and Suspends Rules to Battle COVID-19
In early April 2020, the Centers for Medicare and Medicaid Services (CMS) acted at the direction of President Donald Trump and…
MedPAC Holds Virtual April 2020 Meeting
On April 2, 2020, the Medicare Payment Advisory Commission (MedPAC) held its monthly meeting via a closed session videoconference,…
Kickback Suit Against Novartis for Gilenya Dismissed
In late March, a federal judge dismissed a whistleblower lawsuit against Novartis AG that accused the company of engaging in a…